NovoCure将在2025年ASTRO年会上公布关键3期METIS临床试验最终结果,该试验评估肿瘤电场治疗技术治疗非小细胞肺癌脑转移瘤的疗效

美股速递
Sep 30

NovoCure将在2025年ASTRO年会上公布其关键3期METIS临床试验的最终结果,该试验评估了肿瘤电场治疗技术(TTFields)用于治疗非小细胞肺癌脑转移瘤的疗效。

这项重要的3期临床试验旨在验证肿瘤电场治疗技术在治疗非小细胞肺癌脑转移瘤患者中的临床应用价值。此次在ASTRO年会上的数据展示将为医疗界提供关于该创新疗法最新临床证据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10